Orion Investment Co

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 2033920 ST. LOUIS, MO

Position in ARWR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$5,365,884

+$1,444,940 QoQ

Shares Held

65,831

+5.3% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

1.60%

of 13F equity value

Holder Rank

#125

of 499 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Orion Investment Co holds $49,855,819 across 4 Biotechnology names. ARWR ranks #4 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	29,501	$18,395,053
2	IONS	Ionis Pharmaceuticals Inc	220,335	$17,470,362
3	IOVA	Iovance Biotherapeutics, Inc.	2,073,202	$8,624,520
4	ARWR	Arrowhead Pharmaceuticals, Inc. This page	65,831	$5,365,884

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,365,884	65,831	+5.3%	Shares	Sole	2026-08-11
2026-03-31	$3,920,944	62,535	+34.9%	Shares	Sole	2026-05-12
2025-12-31	$3,078,504	46,370	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.